168 related articles for article (PubMed ID: 17368733)
21. New advances in the second-line treatment of small cell lung cancer.
Hurwitz JL; McCoy F; Scullin P; Fennell DA
Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor as a target in cancer therapy.
Kim ES
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S87-95. PubMed ID: 19795581
[TBL] [Abstract][Full Text] [Related]
24. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
[TBL] [Abstract][Full Text] [Related]
26. Targeting signaling pathways in ovarian cancer.
Reibenwein J; Krainer M
Expert Opin Ther Targets; 2008 Mar; 12(3):353-65. PubMed ID: 18269344
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
Shibata T; Kokubu A; Tsuta K; Hirohashi S
Cancer Lett; 2009 Oct; 283(2):203-11. PubMed ID: 19394761
[TBL] [Abstract][Full Text] [Related]
28. New targeted therapies and small-cell lung cancer.
Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
[TBL] [Abstract][Full Text] [Related]
29. A new era for bronchioloalveolar carcinoma: current state of the art and recent advances in biologically targeted therapy.
Johal BS; Laskin J
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1411-9. PubMed ID: 17069526
[TBL] [Abstract][Full Text] [Related]
30. Molecular and cellular biology of small cell lung cancer.
Sattler M; Salgia R
Semin Oncol; 2003 Feb; 30(1):57-71. PubMed ID: 12635090
[TBL] [Abstract][Full Text] [Related]
31. Cell signaling molecules as drug targets in lung cancer: an overview.
Mukherjee TK; Paul K; Mukhopadhyay S
Curr Opin Pulm Med; 2011 Jul; 17(4):286-91. PubMed ID: 21537189
[TBL] [Abstract][Full Text] [Related]
32. [The place for therapeutic intensification in small cell lung cancer].
Corne F; Thiberville L
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S104-9. PubMed ID: 15536362
[TBL] [Abstract][Full Text] [Related]
33. Targeted therapies for small cell lung cancer: Where do we stand?
Arcaro A
Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
[TBL] [Abstract][Full Text] [Related]
34. Targeting lethal minimal residual disease in small cell lung cancer.
Patel JD; Krug LM; Azzoli CG; Gomez J; Kris MG; Miller VA
Semin Oncol; 2003 Feb; 30(1):79-85. PubMed ID: 12635092
[TBL] [Abstract][Full Text] [Related]
35. Small cell lung cancer: the importance of the extracellular matrix.
Buttery RC; Rintoul RC; Sethi T
Int J Biochem Cell Biol; 2004 Jul; 36(7):1154-60. PubMed ID: 15109562
[TBL] [Abstract][Full Text] [Related]
36. Ganitumab for the treatment of small-cell lung cancer.
MartÃnez P; Sales Fidalgo PA; Felip E
Expert Opin Investig Drugs; 2014 Oct; 23(10):1423-32. PubMed ID: 25189625
[TBL] [Abstract][Full Text] [Related]
37. Current status of clinical trials for small cell lung cancer.
Fischer B; Arcaro A
Rev Recent Clin Trials; 2008 Jan; 3(1):40-61. PubMed ID: 18474014
[TBL] [Abstract][Full Text] [Related]
38. Basic science of small cell lung cancer.
Williams CL
Chest Surg Clin N Am; 1997 Feb; 7(1):1-19. PubMed ID: 9001753
[TBL] [Abstract][Full Text] [Related]
39. Receptor tyrosine kinase alterations and therapeutic opportunities in squamous cell carcinoma of the lung.
Wang D; Du L; Liu Q; Liu X; Wang Z
Cancer Chemother Pharmacol; 2013 Oct; 72(4):725-31. PubMed ID: 23959461
[TBL] [Abstract][Full Text] [Related]
40. Cancer chemopreventive agents-drugs for the 21st century?
Baer-Dubowska W
Acta Pol Pharm; 2006; 63(5):369-73. PubMed ID: 17357586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
